News Category
VERAXA Biotech (NASDAQ: VRXA) is expanding its use of human-relevant preclinical testing methods across its antibody-based cancer drug programs, aimin...
A dual-targeting antibody achieved profound effects in mice across multiple tumor types, offering a potential path to expand immunotherapy's reach to ...
TransCode Therapeutics has initiated a formal strategic review to evaluate options for maximizing the value of its oncology portfolio, including lead ...
A Phase 3 trial shows that combining two immunotherapy drugs extends median survival in patients with a deadly form of lung cancer, signaling a potent...
VolitionRx's nonbinding LOI with Missionpharma aims to develop and commercialize a low-cost, finger-prick NETosis test for neonatal sepsis, potentiall...
The American Heart Association's Support Network provides a free online community for heart disease and stroke patients, survivors, and caregivers to ...
Creative Biolabs has introduced an integrated OMV and exosome-boosted CAR-T development platform to help researchers address poor infiltration, immuno...
Creative Biolabs highlights its tumor organoid and immune cell co-culture services, including CAR-T models, to address limitations of 2D cultures in i...
TransCode Therapeutics' TTX-MC138 met its primary safety endpoint in Phase 1a trials, with no dose-limiting toxicities and early signs of disease stab...
Oncotelic Therapeutics announced a peer-reviewed study showing its AI platform identified a four-gene prognostic signature in liver cancer, which coul...
Coherence Neuro's $45 million Series A, backed by Peter Thiel and OpenAI, will fund the first chronic human trial of its SOMA implant for glioblastoma...
A Yale study finds that recurrent brain cancers develop mutations specific to their subtype, suggesting that treatment should target DNA changes rathe...
ECGI Holdings has hired IBN to expand investor awareness of its healthcare strategy, which includes building an integrated care ecosystem and pursuing...
VERAXA Biotech is implementing New Approach Methodologies across its preclinical cancer research, aiming to generate more clinically relevant data whi...
VERAXA Biotech is advancing its BiTAC platform to develop antibody-based cancer therapies that aim to improve treatment selectivity and reduce toxicit...
Bangladesh's 200,000 suspected measles cases highlight the global risk of falling vaccination rates and the need for sustained public health efforts.
VERAXA Biotech is implementing New Approach Methodologies across its preclinical programs to generate more human-relevant data and reduce animal testi...
Dr. Mona Mofid's ninth Top Doctor recognition and 2026 patient satisfaction awards underscore her peer and patient trust, highlighting the value of sp...
Pentixapharm reports growing international evidence for Pentixafor PET in primary aldosteronism, reinforcing the rationale for its pivotal Phase 3 PAN...
A small German study finds that a new therapeutic vaccine kept two-thirds of patients with aggressive brain tumors alive after eight years, with 42% e...
TransCode Therapeutics will present updated Phase 1a clinical data for its lead candidate TTX-MC138 at the ESMO Congress 2026, highlighting progress i...
Creative BioTherapeutics has been named a 2026 Prix Galien USA Best Startup nominee for its preclinical biologic CBT300, highlighting the urgent chall...
A new experimental vaccine has increased survival times for glioblastoma patients, particularly those under 65, offering a potential breakthrough in a...
Artificial intelligence and next-generation imaging tools are revolutionizing breast cancer detection, enabling earlier diagnosis and personalized scr...
VERAXA Biotech presented first in vivo proof-of-concept data for its BiTAC-ADC platform, demonstrating significant tumor regression in a breast cancer...
A UK study reveals that clearing immune fog could intercept lung cancer early, though some mice still developed cancer, underscoring the need for adva...
VERAXA Biotech presented first in vivo proof-of-concept data for its BiTAC-ADC platform at the World ADC Congress, demonstrating significant tumor reg...
Researchers have uncovered a novel tumor-suppressive circuit in which SPRED2 partners with p53 to activate miR-506-3p, which in turn suppresses KLF4 a...
A modeling analysis presented at the American Heart Association's Hypertension Scientific Sessions 2026 estimates that expanding high blood pressure t...
Flu infections are rising earlier than usual in the U.S., highlighting the importance of accessible diagnostic tools and vaccination to manage the sea...
Consultwebs is providing a $50 stipend and half-day paid time off to encourage employee mammograms, joining Davis, Saperstein & Salomon's EmployersThi...
Avident Health and Unite for HER have been awarded a quality improvement grant from Pfizer and NCCN to deploy a digital navigation platform that bridg...
New guidelines from the American College of Radiology urge women to assess their breast cancer risk by age 25, especially Black and Ashkenazi Jewish w...
VERAXA Biotech's new approach methodologies could accelerate clinical trials, reduce costs, and significantly decrease animal testing in preclinical c...
Lantern Pharma's regulatory and IRB approvals in Taiwan for its Phase 2 HARMONIC trial of LP-300 mark a significant step in advancing a biomarker-driv...
VERAXA Biotech's FDA-aligned New Approach Methodologies could slash animal use by over 90% while accelerating preclinical development of its antibody-...
Telomir Pharmaceuticals (NASDAQ: TELO) raises approximately $5.6 million in a PIPE financing to support the clinical development of Telomir-Zn, includ...
New research reveals lymph node-like structures in the skull's bone marrow, suggesting a local immune defense for the brain that could lead to innovat...
Kairos Pharma's ENV-105 combined with apalutamide significantly extends progression-free survival in metastatic castration-resistant prostate cancer, ...
GeoVax's upcoming presentation on single-dose MVA-X and continuous cell-line manufacturing could streamline vaccination and scale up production for ou...
The Hong Kong Convention and Exhibition Centre hosted 786 events and 25 new exhibitions and conferences in FY 2025–2026, reinforcing Hong Kong's statu...
A new rapid test that identifies a brain tumor's genetic makeup in about two hours instead of eight weeks could accelerate treatment decisions and boo...
A blood-based method for identifying cancer-specific proteins may overcome the need for surgical tumor samples, potentially broadening access to perso...
The College of Optometrists projects over three million UK children will become short-sighted by 18, highlighting the need for early eye tests and tim...
Mega Bee Rescues & Pest Control is turning its signature yellow bee pink and donating 5% of October service revenue to breast cancer efforts, blending...
Blue Faery will host a free liver cancer education event in Chicago on October 24, 2026, to help patients, caregivers, and at-risk individuals underst...
A board-certified vascular surgeon offers laser therapy for venous lake, a common but often unrecognized benign lip lesion, filling a gap in care that...
Onco-Innovations advances its preclinical oncology candidate ONC010 toward a Phase 1 study, backed by a 300-gram API scale-up, a manufacturing partner...
